| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Poliovirus-susceptible Transgenic Mouse Model as a Possible Replacement for the Monkey NeurovirulenceTest of Oral Poliovirus Vaccine
|
Dragunsky, E.
|
|
1996
|
24 |
2 |
p. 77-86
10 p.
|
article
|
| 2 |
Detection of Bovine Polyomavirus Contamination in Fetal Bovine Sera and Modified Live Viral Vaccines Using Polymerase Chain Reaction
|
Kappeler, A.
|
|
1996
|
24 |
2 |
p. 131-135
5 p.
|
article
|
| 3 |
IgG Subclass Antibodies to Human Cytomegalovirus (CMV) in Normal Human Plasma Samples and Immune Globulins and their Neutralizing Activities
|
Gupta, C.K.
|
|
1996
|
24 |
2 |
p. 117-124
8 p.
|
article
|
| 4 |
Improvement of Virus Safety of a S/D-Treated Factor VIII Concentrate by Additional Dry Heat Treatment at 100°C
|
Dichtelmüller, H.
|
|
1996
|
24 |
2 |
p. 125-130
6 p.
|
article
|
| 5 |
Magnesium-mediated Reversal of the Apparent Virucidal Effect of Ascorbic Acid or Congo Red Reacted in vitro with the Human Immunodeficiency Virus
|
Rawal, B.D.
|
|
1996
|
24 |
2 |
p. 113-116
4 p.
|
article
|
| 6 |
Preparation of an Intra-laboratory Reference Material—Determination of the Aluminum Content of a Pooled 5% Albumin (Human) Solution by ETAAS, MFS and ICP-AES
|
Progar, J.J
|
|
1996
|
24 |
2 |
p. 87-93
7 p.
|
article
|
| 7 |
Reduction of the Infectivity of Scrapie Agent as a Model for BSE in the Manufacturing Process of Trasylol®
|
Gölker, C.F.
|
|
1996
|
24 |
2 |
p. 103-111
9 p.
|
article
|
| 8 |
The Use of a Microporous Polyvinylidene Fluoride (PVDF) Membrane Filter to Separate Contaminating Viral Particles from Biologically Important Proteins
|
Oshima, K.H.
|
|
1996
|
24 |
2 |
p. 137-145
9 p.
|
article
|
| 9 |
Use of ELISA for in vitro Potency Test of Rabies Vaccines for Animal Use
|
Gamoh, K.
|
|
1996
|
24 |
2 |
p. 95-101
7 p.
|
article
|
Journal description